Novel motif:140
From FANTOM5_SSTAR
name: | motif140_WTAAATAACG |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0007100 | mitotic centrosome separation | 4.622459e-10 |
GO:0070194 | synaptonemal complex disassembly | 9.230972e-9 |
GO:0031662 | positive regulation of cyclin-dependent protein kinase activity involved in G2/M | 9.230972e-9 |
GO:0006742 | NADP catabolic process | 2.336886e-8 |
GO:0009435 | NAD biosynthetic process | 9.175652e-8 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 1.274022e-7 |
GO:0051299 | centrosome separation | 1.467316e-7 |
GO:0002158 | osteoclast proliferation | 1.927680e-7 |
GO:0050884 | neuromuscular process controlling posture | 1.930931e-7 |
GO:0072526 | pyridine-containing compound catabolic process | 4.213528e-7 |
GO:0060613 | fat pad development | 6.684728e-7 |
GO:0019674 | NAD metabolic process | 7.763424e-7 |
GO:0033211 | adiponectin-mediated signaling pathway | 1.431613e-6 |
GO:0019363 | pyridine nucleotide biosynthetic process | 1.795835e-6 |
GO:0006769 | nicotinamide metabolic process | 2.458958e-6 |
GO:0020028 | hemoglobin import | 3.470459e-6 |
GO:0043044 | ATP-dependent chromatin remodeling | 6.857070e-6 |
GO:0010831 | positive regulation of myotube differentiation | 1.039819e-5 |
GO:0042904 | 9-cis-retinoic acid biosynthetic process | 1.149465e-5 |
GO:0009820 | alkaloid metabolic process | 1.493668e-5 |
GO:0070886 | positive regulation of calcineurin-NFAT signaling pathway | 1.514078e-5 |
GO:0001561 | fatty acid alpha-oxidation | 1.668360e-5 |
GO:0048806 | genitalia development | 2.303740e-5 |
GO:0007412 | axon target recognition | 2.353655e-5 |
GO:0007141 | male meiosis I | 2.706717e-5 |
GO:0007140 | male meiosis | 2.706921e-5 |
GO:0090307 | spindle assembly involved in mitosis | 2.833097e-5 |
GO:0030539 | male genitalia development | 3.711927e-5 |
GO:0042362 | fat-soluble vitamin biosynthetic process | 3.851011e-5 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 4.409729e-5 |
GO:0051935 | glutamate uptake involved in synaptic transmission | 5.087976e-5 |
GO:0046496 | nicotinamide nucleotide metabolic process | 5.188546e-5 |
GO:0021517 | ventral spinal cord development | 5.343246e-5 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 6.533096e-5 |
GO:0010994 | free ubiquitin chain polymerization | 7.575427e-5 |
GO:0046546 | development of primary male sexual characteristics | 1.130547e-4 |
GO:0019362 | pyridine nucleotide metabolic process | 1.289292e-4 |
GO:0044255 | cellular lipid metabolic process | 1.345739e-4 |
GO:0033152 | immunoglobulin V(D)J recombination | 1.469916e-4 |
GO:0019227 | neuronal action potential propagation | 1.615276e-4 |
GO:0070193 | synaptonemal complex organization | 1.712534e-4 |
GO:0032235 | negative regulation of calcium ion transport via store-operated calcium channel activity | 1.762393e-4 |
GO:0002639 | positive regulation of immunoglobulin production | 1.817691e-4 |
GO:0070884 | regulation of calcineurin-NFAT signaling pathway | 1.855498e-4 |
GO:0006957 | complement activation, alternative pathway | 1.979143e-4 |
GO:0035455 | response to interferon-alpha | 1.984574e-4 |
GO:0007628 | adult walking behavior | 2.322999e-4 |
GO:0046661 | male sex differentiation | 2.502609e-4 |
GO:0007041 | lysosomal transport | 2.640389e-4 |
GO:0051938 | L-glutamate import | 2.646398e-4 |
GO:0044249 | cellular biosynthetic process | 3.014209e-4 |
GO:0042573 | retinoic acid metabolic process | 3.285180e-4 |
GO:0002329 | pre-B cell differentiation | 3.414287e-4 |
GO:0034723 | DNA replication-dependent nucleosome organization | 3.890723e-4 |
GO:0051964 | negative regulation of synapse assembly | 4.063990e-4 |
GO:0006733 | oxidoreduction coenzyme metabolic process | 4.074854e-4 |
GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process | 4.241348e-4 |
GO:0007040 | lysosome organization | 4.718096e-4 |
GO:0007219 | Notch signaling pathway | 5.324993e-4 |
GO:0009058 | biosynthetic process | 5.526772e-4 |
GO:0043603 | cellular amide metabolic process | 6.545475e-4 |
GO:0016447 | somatic recombination of immunoglobulin gene segments | 6.633591e-4 |
GO:0043092 | L-amino acid import | 6.680479e-4 |
GO:0033577 | protein glycosylation in endoplasmic reticulum | 6.888884e-4 |
GO:0007034 | vacuolar transport | 7.088812e-4 |
GO:2001016 | positive regulation of skeletal muscle cell differentiation | 7.317985e-4 |
GO:0035640 | exploration behavior | 8.012525e-4 |
GO:0021523 | somatic motor neuron differentiation | 8.500591e-4 |
GO:0010165 | response to X-ray | 8.602370e-4 |
GO:0006325 | chromatin organization | 8.715572e-4 |
GO:0035810 | positive regulation of urine volume | 8.805232e-4 |
GO:0009110 | vitamin biosynthetic process | 9.347345e-4 |
GO:0010761 | fibroblast migration | 9.595608e-4 |
GO:0042359 | vitamin D metabolic process | 1.010826e-3 |
GO:0051769 | regulation of nitric-oxide synthase biosynthetic process | 1.048710e-3 |
GO:0043090 | amino acid import | 1.049618e-3 |
GO:0034725 | DNA replication-dependent nucleosome disassembly | 1.088854e-3 |
GO:0042448 | progesterone metabolic process | 1.091420e-3 |
GO:0060052 | neurofilament cytoskeleton organization | 1.125902e-3 |
GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis | 1.133456e-3 |
GO:0051961 | negative regulation of nervous system development | 1.198741e-3 |
GO:0008610 | lipid biosynthetic process | 1.225152e-3 |
GO:0010807 | regulation of synaptic vesicle priming | 1.248377e-3 |
GO:0055114 | oxidation-reduction process | 1.284700e-3 |
GO:0042572 | retinol metabolic process | 1.313669e-3 |
GO:0001306 | age-dependent response to oxidative stress | 1.318548e-3 |
GO:0060612 | adipose tissue development | 1.378067e-3 |
GO:0016445 | somatic diversification of immunoglobulins | 1.422607e-3 |
GO:0010458 | exit from mitosis | 1.425002e-3 |
GO:0046513 | ceramide biosynthetic process | 1.436363e-3 |
GO:2000833 | positive regulation of steroid hormone secretion | 1.487172e-3 |
GO:0046434 | organophosphate catabolic process | 1.495763e-3 |
GO:0006629 | lipid metabolic process | 1.504446e-3 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 1.539151e-3 |
GO:0022613 | ribonucleoprotein complex biogenesis | 1.540946e-3 |
GO:0002540 | leukotriene production involved in inflammatory response | 1.571071e-3 |
GO:0033688 | regulation of osteoblast proliferation | 1.622476e-3 |
GO:0030325 | adrenal gland development | 1.731544e-3 |
GO:0042694 | muscle cell fate specification | 1.757981e-3 |
GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin | 1.812756e-3 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.819185e-3 |
GO:0045104 | intermediate filament cytoskeleton organization | 1.869887e-3 |
GO:0002702 | positive regulation of production of molecular mediator of immune response | 1.893186e-3 |
GO:0008333 | endosome to lysosome transport | 1.972952e-3 |
GO:0007052 | mitotic spindle organization | 1.972952e-3 |
GO:0015813 | L-glutamate transport | 1.998189e-3 |
GO:0051488 | activation of anaphase-promoting complex activity | 2.124024e-3 |
GO:0045056 | transcytosis | 2.320432e-3 |
GO:0000160 | two-component signal transduction system (phosphorelay) | 2.322358e-3 |
GO:2000831 | regulation of steroid hormone secretion | 2.368439e-3 |
GO:0006766 | vitamin metabolic process | 2.397212e-3 |
GO:0045103 | intermediate filament-based process | 2.421716e-3 |
GO:0042438 | melanin biosynthetic process | 2.432439e-3 |
GO:0008209 | androgen metabolic process | 2.476251e-3 |
GO:0015800 | acidic amino acid transport | 2.525615e-3 |
GO:0035809 | regulation of urine volume | 2.585044e-3 |
GO:0046520 | sphingoid biosynthetic process | 2.680303e-3 |
GO:0007406 | negative regulation of neuroblast proliferation | 2.746297e-3 |
GO:0034622 | cellular macromolecular complex assembly | 2.801305e-3 |
GO:0006338 | chromatin remodeling | 2.843974e-3 |
GO:0002053 | positive regulation of mesenchymal cell proliferation | 2.894578e-3 |
GO:0032787 | monocarboxylic acid metabolic process | 2.922104e-3 |
GO:0035725 | sodium ion transmembrane transport | 2.976496e-3 |
GO:0001667 | ameboidal cell migration | 2.986145e-3 |
GO:0048266 | behavioral response to pain | 3.160128e-3 |
GO:0009268 | response to pH | 3.188527e-3 |
GO:0071843 | cellular component biogenesis at cellular level | 3.194772e-3 |
GO:0022618 | ribonucleoprotein complex assembly | 3.208750e-3 |
GO:0000395 | nuclear mRNA 5'-splice site recognition | 3.305972e-3 |
GO:0001523 | retinoid metabolic process | 3.310682e-3 |
GO:0006927 | transformed cell apoptosis | 3.735950e-3 |
GO:0048193 | Golgi vesicle transport | 3.739404e-3 |
GO:2000794 | regulation of epithelial cell proliferation involved in lung morphogenesis | 3.853952e-3 |
GO:0051155 | positive regulation of striated muscle cell differentiation | 4.012407e-3 |
GO:0061136 | regulation of proteasomal protein catabolic process | 4.023886e-3 |
GO:0006426 | glycyl-tRNA aminoacylation | 4.084660e-3 |
GO:0044264 | cellular polysaccharide metabolic process | 4.208376e-3 |
GO:0016101 | diterpenoid metabolic process | 4.231021e-3 |
GO:0071826 | ribonucleoprotein complex subunit organization | 4.261468e-3 |
GO:0051276 | chromosome organization | 4.285978e-3 |
GO:0043128 | positive regulation of 1-phosphatidylinositol 4-kinase activity | 4.366986e-3 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 4.456641e-3 |
GO:0016568 | chromatin modification | 4.609002e-3 |
GO:0007223 | Wnt receptor signaling pathway, calcium modulating pathway | 4.652344e-3 |
GO:0060685 | regulation of prostatic bud formation | 4.652344e-3 |
GO:0051464 | positive regulation of cortisol secretion | 4.658095e-3 |
GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep | 4.658095e-3 |
GO:0071173 | spindle assembly checkpoint | 4.691868e-3 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 4.739988e-3 |
GO:0060021 | palate development | 4.758213e-3 |
GO:0030148 | sphingolipid biosynthetic process | 4.829204e-3 |
GO:0034621 | cellular macromolecular complex subunit organization | 4.850844e-3 |
GO:0002541 | activation of plasma proteins involved in acute inflammatory response | 4.957927e-3 |
GO:0032438 | melanosome organization | 5.060534e-3 |
GO:0000387 | spliceosomal snRNP assembly | 5.060534e-3 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 5.087048e-3 |
GO:0031577 | spindle checkpoint | 5.138108e-3 |
GO:0051151 | negative regulation of smooth muscle cell differentiation | 5.223998e-3 |
GO:0006582 | melanin metabolic process | 5.252402e-3 |
GO:0006613 | cotranslational protein targeting to membrane | 5.326907e-3 |
GO:0007286 | spermatid development | 5.341681e-3 |
GO:0060028 | convergent extension involved in axis elongation | 5.583523e-3 |
GO:0006776 | vitamin A metabolic process | 5.780495e-3 |
GO:0008207 | C21-steroid hormone metabolic process | 5.791215e-3 |
GO:0007098 | centrosome cycle | 5.836548e-3 |
GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness | 5.909167e-3 |
GO:0016055 | Wnt receptor signaling pathway | 6.101253e-3 |
GO:0048515 | spermatid differentiation | 6.203448e-3 |
GO:0007256 | activation of JNKK activity | 6.234446e-3 |
GO:0015991 | ATP hydrolysis coupled proton transport | 6.437799e-3 |
GO:0019637 | organophosphate metabolic process | 6.470012e-3 |
GO:0010629 | negative regulation of gene expression | 6.486525e-3 |
GO:0016070 | RNA metabolic process | 6.493101e-3 |
GO:0008054 | cyclin catabolic process | 6.542995e-3 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 6.557283e-3 |
GO:0032413 | negative regulation of ion transmembrane transporter activity | 6.664898e-3 |
GO:0007096 | regulation of exit from mitosis | 6.761854e-3 |
GO:0031536 | positive regulation of exit from mitosis | 6.860486e-3 |
GO:0072273 | metanephric nephron morphogenesis | 6.914644e-3 |
GO:0010464 | regulation of mesenchymal cell proliferation | 6.954302e-3 |
GO:0001504 | neurotransmitter uptake | 6.976340e-3 |
GO:0045292 | nuclear mRNA cis splicing, via spliceosome | 7.022604e-3 |
GO:0045861 | negative regulation of proteolysis | 7.456798e-3 |
GO:0048265 | response to pain | 7.462349e-3 |
GO:0045737 | positive regulation of cyclin-dependent protein kinase activity | 7.629456e-3 |
GO:2000063 | positive regulation of ureter smooth muscle cell differentiation | 7.663500e-3 |
GO:2000357 | negative regulation of kidney smooth muscle cell differentiation | 7.663500e-3 |
GO:2000062 | negative regulation of ureter smooth muscle cell differentiation | 7.663500e-3 |
GO:2000358 | positive regulation of kidney smooth muscle cell differentiation | 7.663500e-3 |
GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development | 7.663500e-3 |
GO:0046534 | positive regulation of photoreceptor cell differentiation | 7.663500e-3 |
GO:0007502 | digestive tract mesoderm development | 7.663500e-3 |
GO:0014858 | positive regulation of skeletal muscle cell proliferation | 7.663500e-3 |
GO:0060782 | regulation of mesenchymal cell proliferation involved in prostate gland development | 7.663500e-3 |
GO:0060783 | mesenchymal smoothened signaling pathway involved in prostate gland development | 7.663500e-3 |
GO:0080125 | multicellular structure septum development | 7.663500e-3 |
GO:0006721 | terpenoid metabolic process | 7.804795e-3 |
GO:0048521 | negative regulation of behavior | 7.847610e-3 |
GO:0043438 | acetoacetic acid metabolic process | 7.867215e-3 |
GO:2000173 | negative regulation of branching morphogenesis of a nerve | 8.039182e-3 |
GO:0002562 | somatic diversification of immune receptors via germline recombination within a single locus | 8.103826e-3 |
GO:2000976 | regulation of transcription from RNA polymerase II promoter involved in detection of glucose | 8.423000e-3 |
GO:0000433 | negative regulation of transcription from RNA polymerase II promoter by glucose | 8.423000e-3 |
GO:2000971 | negative regulation of detection of glucose | 8.423000e-3 |
GO:0010605 | negative regulation of macromolecule metabolic process | 8.519293e-3 |
GO:0015986 | ATP synthesis coupled proton transport | 8.672831e-3 |
GO:0035457 | cellular response to interferon-alpha | 8.769157e-3 |
GO:0051462 | regulation of cortisol secretion | 8.814899e-3 |
GO:0003401 | axis elongation | 9.021047e-3 |
GO:0044237 | cellular metabolic process | 9.083386e-3 |
GO:0071841 | cellular component organization or biogenesis at cellular level | 9.141657e-3 |
GO:0016188 | synaptic vesicle maturation | 9.146166e-3 |
GO:0002543 | activation of blood coagulation via clotting cascade | 9.214822e-3 |
GO:0048753 | pigment granule organization | 9.543850e-3 |
GO:0007051 | spindle organization | 9.545359e-3 |
GO:0016539 | intein-mediated protein splicing | 9.622711e-3 |
GO:0003140 | determination of left/right asymmetry in lateral mesoderm | 9.622711e-3 |
GO:0043589 | skin morphogenesis | 9.642498e-3 |
GO:2000300 | regulation of synaptic vesicle exocytosis | 9.729217e-3 |
GO:0010830 | regulation of myotube differentiation | 9.813741e-3 |
GO:0050850 | positive regulation of calcium-mediated signaling | 9.942642e-3 |
GO:0034080 | CenH3-containing nucleosome assembly at centromere | 1.021461e-2 |
GO:0046467 | membrane lipid biosynthetic process | 1.030480e-2 |
GO:0032289 | central nervous system myelin formation | 1.046217e-2 |
GO:0090009 | primitive streak formation | 1.048765e-2 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.074482e-2 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 1.080796e-2 |
GO:0006767 | water-soluble vitamin metabolic process | 1.093818e-2 |
GO:0060029 | convergent extension involved in organogenesis | 1.095899e-2 |
GO:0032237 | activation of store-operated calcium channel activity | 1.095899e-2 |
GO:0060993 | kidney morphogenesis | 1.108828e-2 |
GO:0007257 | activation of JUN kinase activity | 1.111038e-2 |
GO:0002200 | somatic diversification of immune receptors | 1.118693e-2 |
GO:0003338 | metanephros morphogenesis | 1.127735e-2 |
GO:0007228 | positive regulation of hh target transcription factor activity | 1.133282e-2 |
GO:0045602 | negative regulation of endothelial cell differentiation | 1.133282e-2 |
GO:0001705 | ectoderm formation | 1.133282e-2 |
GO:0019605 | butyrate metabolic process | 1.138792e-2 |
GO:0033151 | V(D)J recombination | 1.142823e-2 |
GO:0007033 | vacuole organization | 1.177409e-2 |
GO:0046813 | virion attachment, binding of host cell surface receptor | 1.177971e-2 |
GO:0032410 | negative regulation of transporter activity | 1.192189e-2 |
GO:0050718 | positive regulation of interleukin-1 beta secretion | 1.192353e-2 |
GO:0000186 | activation of MAPKK activity | 1.205697e-2 |
GO:0060447 | bud outgrowth involved in lung branching | 1.223423e-2 |
GO:0033132 | negative regulation of glucokinase activity | 1.223423e-2 |
GO:0016264 | gap junction assembly | 1.227450e-2 |
GO:0045014 | negative regulation of transcription by glucose | 1.269633e-2 |
GO:0006528 | asparagine metabolic process | 1.269633e-2 |
GO:0010467 | gene expression | 1.283650e-2 |
GO:0072001 | renal system development | 1.283999e-2 |
GO:0006631 | fatty acid metabolic process | 1.301338e-2 |
GO:0035264 | multicellular organism growth | 1.306887e-2 |
GO:0045839 | negative regulation of mitosis | 1.328795e-2 |
GO:0045137 | development of primary sexual characteristics | 1.336416e-2 |
GO:0065003 | macromolecular complex assembly | 1.366980e-2 |
GO:0070527 | platelet aggregation | 1.367665e-2 |
GO:0009062 | fatty acid catabolic process | 1.375436e-2 |
GO:0006672 | ceramide metabolic process | 1.376261e-2 |
GO:0008299 | isoprenoid biosynthetic process | 1.392900e-2 |
GO:0060459 | left lung development | 1.412757e-2 |
GO:0042953 | lipoprotein transport | 1.418482e-2 |
GO:0050716 | positive regulation of interleukin-1 secretion | 1.430381e-2 |
GO:0031055 | chromatin remodeling at centromere | 1.430381e-2 |
GO:0003006 | developmental process involved in reproduction | 1.433983e-2 |
GO:0031047 | gene silencing by RNA | 1.438794e-2 |
GO:0060026 | convergent extension | 1.447238e-2 |
GO:0002377 | immunoglobulin production | 1.457273e-2 |
GO:0009165 | nucleotide biosynthetic process | 1.489869e-2 |
GO:0061002 | negative regulation of dendritic spine morphogenesis | 1.511864e-2 |
GO:0045652 | regulation of megakaryocyte differentiation | 1.533405e-2 |
GO:0051188 | cofactor biosynthetic process | 1.550507e-2 |
GO:0006351 | transcription, DNA-dependent | 1.553180e-2 |
GO:0061056 | sclerotome development | 1.562509e-2 |
GO:0009987 | cellular process | 1.598072e-2 |
GO:0009108 | coenzyme biosynthetic process | 1.615545e-2 |
GO:0060285 | ciliary cell motility | 1.665955e-2 |
GO:0008628 | induction of apoptosis by hormones | 1.665955e-2 |
GO:0045329 | carnitine biosynthetic process | 1.665955e-2 |
GO:0060676 | ureteric bud formation | 1.674363e-2 |
GO:0010259 | multicellular organismal aging | 1.705365e-2 |
GO:0009791 | post-embryonic development | 1.718677e-2 |
GO:0010948 | negative regulation of cell cycle process | 1.738989e-2 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 1.748996e-2 |
GO:0015807 | L-amino acid transport | 1.754017e-2 |
GO:0007411 | axon guidance | 1.771410e-2 |
GO:0008584 | male gonad development | 1.771744e-2 |
GO:0072210 | metanephric nephron development | 1.778696e-2 |
GO:0048745 | smooth muscle tissue development | 1.778696e-2 |
GO:0072329 | monocarboxylic acid catabolic process | 1.787087e-2 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 1.826438e-2 |
GO:0019752 | carboxylic acid metabolic process | 1.867121e-2 |
GO:0060157 | urinary bladder development | 1.869573e-2 |
GO:0006386 | termination of RNA polymerase III transcription | 1.869573e-2 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.869573e-2 |
GO:0006082 | organic acid metabolic process | 1.876412e-2 |
GO:0007019 | microtubule depolymerization | 1.881328e-2 |
GO:0021904 | dorsal/ventral neural tube patterning | 1.889977e-2 |
GO:0021510 | spinal cord development | 1.890786e-2 |
GO:0046459 | short-chain fatty acid metabolic process | 1.898445e-2 |
GO:0072028 | nephron morphogenesis | 1.905669e-2 |
GO:0072136 | metanephric mesenchymal cell proliferation involved in metanephros development | 1.936908e-2 |
GO:0007254 | JNK cascade | 1.938182e-2 |
GO:0018191 | peptidyl-serine octanoylation | 1.945300e-2 |
GO:0014047 | glutamate secretion | 1.984747e-2 |
GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation | 1.993172e-2 |
GO:0034645 | cellular macromolecule biosynthetic process | 2.017060e-2 |
GO:0007548 | sex differentiation | 2.030855e-2 |
GO:0033628 | regulation of cell adhesion mediated by integrin | 2.038688e-2 |
GO:0072199 | regulation of mesenchymal cell proliferation involved in ureter development | 2.050116e-2 |
GO:0043933 | macromolecular complex subunit organization | 2.061171e-2 |
GO:0033630 | positive regulation of cell adhesion mediated by integrin | 2.075317e-2 |
GO:0000723 | telomere maintenance | 2.093615e-2 |
GO:0033555 | multicellular organismal response to stress | 2.129603e-2 |
GO:0006739 | NADP metabolic process | 2.139486e-2 |
GO:0032851 | positive regulation of Rab GTPase activity | 2.141750e-2 |
GO:0070295 | renal water absorption | 2.166022e-2 |
GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process | 2.169398e-2 |
GO:0035270 | endocrine system development | 2.185380e-2 |
GO:0001708 | cell fate specification | 2.187418e-2 |
GO:0032229 | negative regulation of synaptic transmission, GABAergic | 2.200739e-2 |
GO:0016572 | histone phosphorylation | 2.249109e-2 |
GO:0030162 | regulation of proteolysis | 2.253728e-2 |
GO:0071318 | cellular response to ATP | 2.284585e-2 |
GO:0007442 | hindgut morphogenesis | 2.316496e-2 |
GO:0071842 | cellular component organization at cellular level | 2.329982e-2 |
GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep | 2.344851e-2 |
GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter | 2.344851e-2 |
GO:0009059 | macromolecule biosynthetic process | 2.350314e-2 |
GO:0009892 | negative regulation of metabolic process | 2.356673e-2 |
GO:0046519 | sphingoid metabolic process | 2.360653e-2 |
GO:0016339 | calcium-dependent cell-cell adhesion | 2.385098e-2 |
GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development | 2.405767e-2 |
GO:0048859 | formation of anatomical boundary | 2.405767e-2 |
GO:0007418 | ventral midline development | 2.405767e-2 |
GO:0042180 | cellular ketone metabolic process | 2.432860e-2 |
GO:0071840 | cellular component organization or biogenesis | 2.434866e-2 |
GO:0032774 | RNA biosynthetic process | 2.436341e-2 |
GO:0007266 | Rho protein signal transduction | 2.445866e-2 |
GO:0060324 | face development | 2.447316e-2 |
GO:0045444 | fat cell differentiation | 2.449423e-2 |
GO:2001014 | regulation of skeletal muscle cell differentiation | 2.454920e-2 |
GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development | 2.467327e-2 |
GO:0035092 | sperm chromatin condensation | 2.467327e-2 |
GO:0051225 | spindle assembly | 2.521614e-2 |
GO:0032236 | positive regulation of calcium ion transport via store-operated calcium channel activity | 2.527725e-2 |
GO:0051301 | cell division | 2.544397e-2 |
GO:0006260 | DNA replication | 2.557450e-2 |
GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep | 2.592363e-2 |
GO:0000432 | positive regulation of transcription from RNA polymerase II promoter by glucose | 2.592363e-2 |
GO:0060441 | epithelial tube branching involved in lung morphogenesis | 2.597459e-2 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 2.598240e-2 |
GO:0060292 | long term synaptic depression | 2.630632e-2 |
GO:0050706 | regulation of interleukin-1 beta secretion | 2.647106e-2 |
GO:0005977 | glycogen metabolic process | 2.682034e-2 |
GO:0034063 | stress granule assembly | 2.700467e-2 |
GO:0033092 | positive regulation of immature T cell proliferation in thymus | 2.719919e-2 |
GO:0035567 | non-canonical Wnt receptor signaling pathway | 2.721433e-2 |
GO:0042113 | B cell activation | 2.725862e-2 |
GO:0008344 | adult locomotory behavior | 2.759397e-2 |
GO:0032200 | telomere organization | 2.781603e-2 |
GO:0061349 | planar cell polarity pathway involved in cardiac right atrium morphogenesis | 2.784631e-2 |
GO:0061350 | planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | 2.784631e-2 |
GO:0061354 | planar cell polarity pathway involved in pericardium morphogenesis | 2.784631e-2 |
GO:0061347 | planar cell polarity pathway involved in outflow tract morphogenesis | 2.784631e-2 |
GO:0051594 | detection of glucose | 2.784631e-2 |
GO:0060210 | metestrus | 2.784631e-2 |
GO:0061348 | planar cell polarity pathway involved in ventricular septum morphogenesis | 2.784631e-2 |
GO:0060325 | face morphogenesis | 2.793968e-2 |
GO:0007568 | aging | 2.814137e-2 |
GO:0006073 | cellular glucan metabolic process | 2.841420e-2 |
GO:0007289 | spermatid nucleus differentiation | 2.879358e-2 |
GO:0007018 | microtubule-based movement | 2.911583e-2 |
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 2.951848e-2 |
GO:0060458 | right lung development | 2.982444e-2 |
GO:0048008 | platelet-derived growth factor receptor signaling pathway | 2.991774e-2 |
GO:0050704 | regulation of interleukin-1 secretion | 3.031140e-2 |
GO:0035641 | locomotory exploration behavior | 3.117337e-2 |
GO:0030202 | heparin metabolic process | 3.117337e-2 |
GO:0043486 | histone exchange | 3.138803e-2 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 3.152036e-2 |
GO:0033189 | response to vitamin A | 3.156469e-2 |
GO:0055098 | response to low-density lipoprotein particle stimulus | 3.178325e-2 |
GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation | 3.185675e-2 |
GO:0001655 | urogenital system development | 3.237277e-2 |
GO:0060067 | cervix development | 3.254601e-2 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 3.287558e-2 |
GO:0014043 | negative regulation of neuron maturation | 3.324111e-2 |
GO:0070979 | protein K11-linked ubiquitination | 3.332566e-2 |
GO:0033205 | cell cycle cytokinesis | 3.333663e-2 |
GO:0072376 | protein activation cascade | 3.333861e-2 |
GO:0002532 | production of molecular mediator involved in inflammatory response | 3.360804e-2 |
GO:0019748 | secondary metabolic process | 3.390961e-2 |
GO:0072092 | ureteric bud invasion | 3.394199e-2 |
GO:0060161 | positive regulation of dopamine receptor signaling pathway | 3.394199e-2 |
GO:0051297 | centrosome organization | 3.409476e-2 |
GO:0003014 | renal system process | 3.441007e-2 |
GO:0044085 | cellular component biogenesis | 3.469745e-2 |
GO:2000177 | regulation of neural precursor cell proliferation | 3.491647e-2 |
GO:0016197 | endosome transport | 3.494287e-2 |
GO:0060675 | ureteric bud morphogenesis | 3.497772e-2 |
GO:0048850 | hypophysis morphogenesis | 3.536096e-2 |
GO:0051261 | protein depolymerization | 3.536096e-2 |
GO:0035564 | regulation of kidney size | 3.536096e-2 |
GO:0051253 | negative regulation of RNA metabolic process | 3.537082e-2 |
GO:0060286 | flagellar cell motility | 3.537492e-2 |
GO:0019373 | epoxygenase P450 pathway | 3.537492e-2 |
GO:0043651 | linoleic acid metabolic process | 3.537492e-2 |
GO:2000027 | regulation of organ morphogenesis | 3.544797e-2 |
GO:0045494 | photoreceptor cell maintenance | 3.562375e-2 |
GO:0006353 | transcription termination, DNA-dependent | 3.594404e-2 |
GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation | 3.607895e-2 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 3.623941e-2 |
GO:0002440 | production of molecular mediator of immune response | 3.664007e-2 |
GO:0050848 | regulation of calcium-mediated signaling | 3.669505e-2 |
GO:0003097 | renal water transport | 3.680255e-2 |
GO:0022409 | positive regulation of cell-cell adhesion | 3.681545e-2 |
GO:0002637 | regulation of immunoglobulin production | 3.704412e-2 |
GO:0060323 | head morphogenesis | 3.714961e-2 |
GO:0006996 | organelle organization | 3.733316e-2 |
GO:0072093 | metanephric renal vesicle formation | 3.753172e-2 |
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 3.753172e-2 |
GO:0033131 | regulation of glucokinase activity | 3.753172e-2 |
GO:0019062 | virion attachment to host cell surface receptor | 3.753172e-2 |
GO:0031670 | cellular response to nutrient | 3.779676e-2 |
GO:0060322 | head development | 3.820015e-2 |
GO:0021891 | olfactory bulb interneuron development | 3.865239e-2 |
GO:0032414 | positive regulation of ion transmembrane transporter activity | 3.887371e-2 |
GO:0005980 | glycogen catabolic process | 3.892970e-2 |
GO:0051926 | negative regulation of calcium ion transport | 3.954899e-2 |
GO:0061290 | canonical Wnt receptor signaling pathway involved in metanephric kidney development | 3.975218e-2 |
GO:0048312 | intracellular distribution of mitochondria | 3.975218e-2 |
GO:0003344 | pericardium morphogenesis | 3.975218e-2 |
GO:0043369 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 3.975218e-2 |
GO:0090304 | nucleic acid metabolic process | 3.989387e-2 |
GO:0051597 | response to methylmercury | 3.993669e-2 |
GO:2000178 | negative regulation of neural precursor cell proliferation | 4.048841e-2 |
GO:0060516 | primary prostatic bud elongation | 4.050318e-2 |
GO:0046015 | regulation of transcription by glucose | 4.050318e-2 |
GO:0001822 | kidney development | 4.092529e-2 |
GO:0009109 | coenzyme catabolic process | 4.112170e-2 |
GO:0003341 | cilium movement | 4.125953e-2 |
GO:0002741 | positive regulation of cytokine secretion involved in immune response | 4.125953e-2 |
GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 4.202118e-2 |
GO:0044247 | cellular polysaccharide catabolic process | 4.240508e-2 |
GO:0009251 | glucan catabolic process | 4.240508e-2 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 4.248059e-2 |
GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis | 4.278810e-2 |
GO:0001302 | replicative cell aging | 4.278810e-2 |
GO:0007270 | neuron-neuron synaptic transmission | 4.297499e-2 |
GO:0048096 | chromatin-mediated maintenance of transcription | 4.301646e-2 |
GO:0035987 | endodermal cell differentiation | 4.301646e-2 |
GO:0090090 | negative regulation of canonical Wnt receptor signaling pathway | 4.313970e-2 |
GO:0048808 | male genitalia morphogenesis | 4.356024e-2 |
GO:0016255 | attachment of GPI anchor to protein | 4.356024e-2 |
GO:0060677 | ureteric bud elongation | 4.433756e-2 |
GO:0034660 | ncRNA metabolic process | 4.455516e-2 |
GO:0043004 | cytoplasmic sequestering of CFTR protein | 4.480390e-2 |
GO:0016043 | cellular component organization | 4.501966e-2 |
GO:0007398 | ectoderm development | 4.503903e-2 |
GO:0060406 | positive regulation of penile erection | 4.512002e-2 |
GO:0010498 | proteasomal protein catabolic process | 4.526848e-2 |
GO:0006139 | nucleobase-containing compound metabolic process | 4.562512e-2 |
GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development | 4.574807e-2 |
GO:0006654 | phosphatidic acid biosynthetic process | 4.590757e-2 |
GO:0003408 | optic cup formation involved in camera-type eye development | 4.590757e-2 |
GO:0071299 | cellular response to vitamin A | 4.598875e-2 |
GO:0032785 | negative regulation of transcription elongation, DNA-dependent | 4.670018e-2 |
GO:0006704 | glucocorticoid biosynthetic process | 4.749779e-2 |
GO:0034754 | cellular hormone metabolic process | 4.752489e-2 |
GO:0050679 | positive regulation of epithelial cell proliferation | 4.839668e-2 |
GO:0043507 | positive regulation of JUN kinase activity | 4.843305e-2 |
GO:0031327 | negative regulation of cellular biosynthetic process | 4.843750e-2 |
GO:0007598 | blood coagulation, extrinsic pathway | 4.910791e-2 |
GO:0061053 | somite development | 4.912357e-2 |
GO:0021781 | glial cell fate commitment | 4.950994e-2 |
GO:0003323 | type B pancreatic cell development | 4.952042e-2 |
GO:0001736 | establishment of planar polarity | 4.952042e-2 |
GO:2000484 | positive regulation of interleukin-8 secretion | 4.992032e-2 |
GO:0010508 | positive regulation of autophagy | 4.992032e-2 |
GO:0019395 | fatty acid oxidation | 5.019914e-2 |
GO:0006396 | RNA processing | 5.031784e-2 |
GO:0048016 | inositol phosphate-mediated signaling | 5.049592e-2 |
GO:0072075 | metanephric mesenchyme development | 5.097302e-2 |
GO:0060601 | lateral sprouting from an epithelium | 5.097302e-2 |
GO:0015711 | organic anion transport | 5.105594e-2 |
GO:0072088 | nephron epithelium morphogenesis | 5.122289e-2 |
GO:0034587 | piRNA metabolic process | 5.155965e-2 |
GO:0002011 | morphogenesis of an epithelial sheet | 5.195282e-2 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 5.224386e-2 |
GO:0007193 | inhibition of adenylate cyclase activity by G-protein signaling pathway | 5.293081e-2 |
GO:0030534 | adult behavior | 5.320336e-2 |
GO:0046668 | regulation of retinal cell programmed cell death | 5.321805e-2 |
GO:0006112 | energy reserve metabolic process | 5.330834e-2 |
GO:0044283 | small molecule biosynthetic process | 5.331228e-2 |
GO:0046394 | carboxylic acid biosynthetic process | 5.333965e-2 |
GO:0048678 | response to axon injury | 5.334199e-2 |
GO:0015672 | monovalent inorganic cation transport | 5.341326e-2 |
GO:0006775 | fat-soluble vitamin metabolic process | 5.343700e-2 |
GO:0008380 | RNA splicing | 5.351883e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0090273 | regulation of somatostatin secretion | 2.051119e-11 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.396748e-8 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 2.822043e-8 |
GO:0031648 | protein destabilization | 7.759079e-8 |
GO:0048266 | behavioral response to pain | 1.875367e-7 |
GO:0048265 | response to pain | 4.299229e-7 |
GO:0007089 | traversing start control point of mitotic cell cycle | 5.432077e-7 |
GO:0034725 | DNA replication-dependent nucleosome disassembly | 8.369541e-7 |
GO:0007632 | visual behavior | 1.078022e-6 |
GO:0032412 | regulation of ion transmembrane transporter activity | 1.379964e-6 |
GO:0071844 | cellular component assembly at cellular level | 1.458791e-6 |
GO:0035845 | photoreceptor cell outer segment organization | 1.460867e-6 |
GO:0001662 | behavioral fear response | 1.499436e-6 |
GO:0002209 | behavioral defense response | 1.582473e-6 |
GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus | 1.807623e-6 |
GO:0008542 | visual learning | 2.161056e-6 |
GO:0046381 | CMP-N-acetylneuraminate metabolic process | 2.354036e-6 |
GO:0000398 | nuclear mRNA splicing, via spliceosome | 2.789055e-6 |
GO:0022898 | regulation of transmembrane transporter activity | 3.345914e-6 |
GO:0002158 | osteoclast proliferation | 3.487901e-6 |
GO:0000375 | RNA splicing, via transesterification reactions | 3.852479e-6 |
GO:0042596 | fear response | 4.108850e-6 |
GO:0042593 | glucose homeostasis | 7.140406e-6 |
GO:0006376 | mRNA splice site selection | 7.918425e-6 |
GO:0006054 | N-acetylneuraminate metabolic process | 9.785336e-6 |
GO:0048002 | antigen processing and presentation of peptide antigen | 1.013308e-5 |
GO:0034621 | cellular macromolecular complex subunit organization | 1.103616e-5 |
GO:0032409 | regulation of transporter activity | 1.209552e-5 |
GO:0007212 | dopamine receptor signaling pathway | 1.397331e-5 |
GO:0060807 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification | 1.491920e-5 |
GO:0003142 | cardiogenic plate morphogenesis | 1.491920e-5 |
GO:0001828 | inner cell mass cellular morphogenesis | 1.491920e-5 |
GO:0007008 | outer mitochondrial membrane organization | 1.646627e-5 |
GO:0030317 | sperm motility | 2.249335e-5 |
GO:0060956 | endocardial cell differentiation | 2.765482e-5 |
GO:0010994 | free ubiquitin chain polymerization | 3.309978e-5 |
GO:0048026 | positive regulation of nuclear mRNA splicing, via spliceosome | 3.463988e-5 |
GO:0010458 | exit from mitosis | 3.736461e-5 |
GO:0051924 | regulation of calcium ion transport | 4.879357e-5 |
GO:0051925 | regulation of calcium ion transport via voltage-gated calcium channel activity | 5.137243e-5 |
GO:2000121 | regulation of removal of superoxide radicals | 5.339714e-5 |
GO:0045861 | negative regulation of proteolysis | 5.533959e-5 |
GO:0048866 | stem cell fate specification | 6.182292e-5 |
GO:0000245 | spliceosome assembly | 6.279175e-5 |
GO:0022607 | cellular component assembly | 6.780988e-5 |
GO:2000035 | regulation of stem cell division | 7.091225e-5 |
GO:0045844 | positive regulation of striated muscle tissue development | 7.291534e-5 |
GO:0071157 | negative regulation of cell cycle arrest | 7.865729e-5 |
GO:2000466 | negative regulation of glycogen (starch) synthase activity | 8.083275e-5 |
GO:0046415 | urate metabolic process | 9.741064e-5 |
GO:0031529 | ruffle organization | 1.010189e-4 |
GO:0021784 | postganglionic parasympathetic nervous system development | 1.032997e-4 |
GO:0060913 | cardiac cell fate determination | 1.032997e-4 |
GO:0010172 | embryonic body morphogenesis | 1.047289e-4 |
GO:0033555 | multicellular organismal response to stress | 1.098879e-4 |
GO:0016071 | mRNA metabolic process | 1.192367e-4 |
GO:0019882 | antigen processing and presentation | 1.196268e-4 |
GO:0048643 | positive regulation of skeletal muscle tissue development | 1.234021e-4 |
GO:0061031 | endodermal digestive tract morphogenesis | 1.294849e-4 |
GO:0048865 | stem cell fate commitment | 1.294849e-4 |
GO:0042662 | negative regulation of mesodermal cell fate specification | 1.440519e-4 |
GO:0043249 | erythrocyte maturation | 1.536760e-4 |
GO:0008306 | associative learning | 1.583657e-4 |
GO:2000043 | regulation of cardiac cell fate specification | 2.128761e-4 |
GO:0010959 | regulation of metal ion transport | 2.241234e-4 |
GO:0033120 | positive regulation of RNA splicing | 2.260981e-4 |
GO:2000500 | positive regulation of induction of apoptosis in response to chemical stimulus | 2.540473e-4 |
GO:2000836 | positive regulation of androgen secretion | 2.540473e-4 |
GO:0048250 | mitochondrial iron ion transport | 2.540473e-4 |
GO:0035260 | internal genitalia morphogenesis | 2.540473e-4 |
GO:0006338 | chromatin remodeling | 2.577139e-4 |
GO:0001714 | endodermal cell fate specification | 2.586919e-4 |
GO:0034765 | regulation of ion transmembrane transport | 2.996258e-4 |
GO:0045931 | positive regulation of mitotic cell cycle | 3.433949e-4 |
GO:0006397 | mRNA processing | 3.549784e-4 |
GO:0031536 | positive regulation of exit from mitosis | 3.785698e-4 |
GO:0045995 | regulation of embryonic development | 3.923405e-4 |
GO:0043628 | ncRNA 3'-end processing | 4.074024e-4 |
GO:0003348 | cardiac endothelial cell differentiation | 4.074024e-4 |
GO:0009225 | nucleotide-sugar metabolic process | 4.222608e-4 |
GO:0008380 | RNA splicing | 4.658231e-4 |
GO:0060968 | regulation of gene silencing | 4.739948e-4 |
GO:0006396 | RNA processing | 4.754997e-4 |
GO:0044085 | cellular component biogenesis | 4.948816e-4 |
GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 5.022488e-4 |
GO:0034337 | RNA folding | 5.100718e-4 |
GO:0048251 | elastic fiber assembly | 5.288234e-4 |
GO:0070060 | 'de novo' actin filament nucleation | 5.365542e-4 |
GO:0060214 | endocardium formation | 5.367354e-4 |
GO:0032236 | positive regulation of calcium ion transport via store-operated calcium channel activity | 5.677878e-4 |
GO:0000080 | G1 phase of mitotic cell cycle | 5.677878e-4 |
GO:0034622 | cellular macromolecular complex assembly | 5.714058e-4 |
GO:0001826 | inner cell mass cell differentiation | 6.101712e-4 |
GO:0034623 | cellular macromolecular complex disassembly | 6.249833e-4 |
GO:0044029 | hypomethylation of CpG island | 6.299939e-4 |
GO:0022900 | electron transport chain | 6.617668e-4 |
GO:2000833 | positive regulation of steroid hormone secretion | 6.897257e-4 |
GO:0051584 | regulation of dopamine uptake | 6.897257e-4 |
GO:0003308 | negative regulation of Wnt receptor signaling pathway involved in heart development | 6.897257e-4 |
GO:0034728 | nucleosome organization | 6.928923e-4 |
GO:0032984 | macromolecular complex disassembly | 7.172254e-4 |
GO:0035907 | dorsal aorta development | 7.318594e-4 |
GO:0002027 | regulation of heart rate | 7.449431e-4 |
GO:0006710 | androgen catabolic process | 7.833159e-4 |
GO:0019233 | sensory perception of pain | 7.840390e-4 |
GO:0085029 | extracellular matrix assembly | 8.192851e-4 |
GO:0046548 | retinal rod cell development | 8.209614e-4 |
GO:0048096 | chromatin-mediated maintenance of transcription | 8.209614e-4 |
GO:0030032 | lamellipodium assembly | 8.533629e-4 |
GO:2000831 | regulation of steroid hormone secretion | 8.679772e-4 |
GO:0061010 | gall bladder development | 8.679772e-4 |
GO:2000279 | negative regulation of DNA biosynthetic process | 8.722365e-4 |
GO:0007612 | learning | 8.963360e-4 |
GO:0042780 | tRNA 3'-end processing | 9.236001e-4 |
GO:0032235 | negative regulation of calcium ion transport via store-operated calcium channel activity | 9.236001e-4 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 9.236001e-4 |
GO:0051254 | positive regulation of RNA metabolic process | 9.689221e-4 |
GO:0090322 | regulation of superoxide metabolic process | 9.852933e-4 |
GO:0007493 | endodermal cell fate determination | 1.019163e-3 |
GO:0035810 | positive regulation of urine volume | 1.073014e-3 |
GO:0007096 | regulation of exit from mitosis | 1.073014e-3 |
GO:0070358 | actin polymerization-dependent cell motility | 1.075047e-3 |
GO:0033688 | regulation of osteoblast proliferation | 1.076571e-3 |
GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.128629e-3 |
GO:0050685 | positive regulation of mRNA processing | 1.140617e-3 |
GO:0072107 | positive regulation of ureteric bud formation | 1.186031e-3 |
GO:0006337 | nucleosome disassembly | 1.186031e-3 |
GO:0061009 | common bile duct development | 1.186031e-3 |
GO:0045585 | positive regulation of cytotoxic T cell differentiation | 1.237577e-3 |
GO:0008016 | regulation of heart contraction | 1.243920e-3 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.245242e-3 |
GO:0051045 | negative regulation of membrane protein ectodomain proteolysis | 1.276634e-3 |
GO:0022618 | ribonucleoprotein complex assembly | 1.285291e-3 |
GO:0010677 | negative regulation of cellular carbohydrate metabolic process | 1.287829e-3 |
GO:0003093 | regulation of glomerular filtration | 1.306281e-3 |
GO:0042661 | regulation of mesodermal cell fate specification | 1.306281e-3 |
GO:0048743 | positive regulation of skeletal muscle fiber development | 1.385805e-3 |
GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 1.462101e-3 |
GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway | 1.499400e-3 |
GO:0007346 | regulation of mitotic cell cycle | 1.499921e-3 |
GO:0008054 | cyclin catabolic process | 1.500586e-3 |
GO:0006744 | ubiquinone biosynthetic process | 1.500586e-3 |
GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway | 1.541275e-3 |
GO:0071826 | ribonucleoprotein complex subunit organization | 1.629355e-3 |
GO:0030910 | olfactory placode formation | 1.639647e-3 |
GO:0006040 | amino sugar metabolic process | 1.643978e-3 |
GO:0001711 | endodermal cell fate commitment | 1.665555e-3 |
GO:0009451 | RNA modification | 1.792431e-3 |
GO:0043269 | regulation of ion transport | 1.935656e-3 |
GO:0051318 | G1 phase | 1.982281e-3 |
GO:0046549 | retinal cone cell development | 2.104261e-3 |
GO:0045426 | quinone cofactor biosynthetic process | 2.104261e-3 |
GO:0001977 | renal system process involved in regulation of blood volume | 2.104261e-3 |
GO:0006333 | chromatin assembly or disassembly | 2.163143e-3 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 2.202035e-3 |
GO:0034755 | iron ion transmembrane transport | 2.275439e-3 |
GO:0009996 | negative regulation of cell fate specification | 2.275439e-3 |
GO:0035082 | axoneme assembly | 2.364166e-3 |
GO:0034766 | negative regulation of ion transmembrane transport | 2.441125e-3 |
GO:0045719 | negative regulation of glycogen biosynthetic process | 2.455008e-3 |
GO:0032274 | gonadotropin secretion | 2.503616e-3 |
GO:0034349 | glial cell apoptosis | 2.547982e-3 |
GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 2.560433e-3 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 2.565759e-3 |
GO:0043154 | negative regulation of caspase activity | 2.654474e-3 |
GO:0071347 | cellular response to interleukin-1 | 2.778739e-3 |
GO:0051580 | regulation of neurotransmitter uptake | 3.045402e-3 |
GO:0010454 | negative regulation of cell fate commitment | 3.151508e-3 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 3.178012e-3 |
GO:0090288 | negative regulation of cellular response to growth factor stimulus | 3.178012e-3 |
GO:0070874 | negative regulation of glycogen metabolic process | 3.259856e-3 |
GO:0009416 | response to light stimulus | 3.288381e-3 |
GO:0003014 | renal system process | 3.325964e-3 |
GO:0042375 | quinone cofactor metabolic process | 3.370463e-3 |
GO:2000278 | regulation of DNA biosynthetic process | 3.451127e-3 |
GO:0045746 | negative regulation of Notch signaling pathway | 3.451127e-3 |
GO:0035987 | endodermal cell differentiation | 3.451127e-3 |
GO:0070932 | histone H3 deacetylation | 3.455330e-3 |
GO:2000380 | regulation of mesoderm development | 3.483342e-3 |
GO:2001021 | negative regulation of response to DNA damage stimulus | 3.521816e-3 |
GO:0070555 | response to interleukin-1 | 3.538137e-3 |
GO:0035809 | regulation of urine volume | 3.598508e-3 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 3.602826e-3 |
GO:0044030 | regulation of DNA methylation | 3.666131e-3 |
GO:0031128 | developmental induction | 3.827553e-3 |
GO:0016202 | regulation of striated muscle tissue development | 3.904150e-3 |
GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling | 4.082323e-3 |
GO:0060676 | ureteric bud formation | 4.082323e-3 |
GO:0001522 | pseudouridine synthesis | 4.082323e-3 |
GO:0070588 | calcium ion transmembrane transport | 4.123126e-3 |
GO:0048634 | regulation of muscle organ development | 4.178526e-3 |
GO:0071899 | negative regulation of estrogen receptor binding | 4.469869e-3 |
GO:0003160 | endocardium morphogenesis | 4.469869e-3 |
GO:0034616 | response to laminar fluid shear stress | 4.789989e-3 |
GO:0051179 | localization | 5.097938e-3 |
GO:0043933 | macromolecular complex subunit organization | 5.107939e-3 |
GO:0045168 | cell-cell signaling involved in cell fate commitment | 5.158614e-3 |
GO:0030432 | peristalsis | 5.163821e-3 |
GO:0031647 | regulation of protein stability | 5.265624e-3 |
GO:0060911 | cardiac cell fate commitment | 5.309925e-3 |
GO:0035305 | negative regulation of dephosphorylation | 5.309925e-3 |
GO:2001020 | regulation of response to DNA damage stimulus | 5.384705e-3 |
GO:0050680 | negative regulation of epithelial cell proliferation | 5.497882e-3 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 5.563143e-3 |
GO:0030162 | regulation of proteolysis | 5.728095e-3 |
GO:0071842 | cellular component organization at cellular level | 5.837850e-3 |
GO:0045815 | positive regulation of gene expression, epigenetic | 5.919102e-3 |
GO:0010498 | proteasomal protein catabolic process | 5.953129e-3 |
GO:0034619 | cellular chaperone-mediated protein complex assembly | 5.970507e-3 |
GO:0034983 | peptidyl-lysine deacetylation | 5.970507e-3 |
GO:0007626 | locomotory behavior | 6.013996e-3 |
GO:0032715 | negative regulation of interleukin-6 production | 6.021982e-3 |
GO:0071383 | cellular response to steroid hormone stimulus | 6.236038e-3 |
GO:0032414 | positive regulation of ion transmembrane transporter activity | 6.333459e-3 |
GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development | 6.402280e-3 |
GO:0007059 | chromosome segregation | 6.491241e-3 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 6.528329e-3 |
GO:0008633 | activation of pro-apoptotic gene products | 6.568401e-3 |
GO:0040019 | positive regulation of embryonic development | 6.655446e-3 |
GO:0080135 | regulation of cellular response to stress | 6.777285e-3 |
GO:0007431 | salivary gland development | 6.936209e-3 |
GO:0040030 | regulation of molecular function, epigenetic | 7.074992e-3 |
GO:0007216 | metabotropic glutamate receptor signaling pathway | 7.074992e-3 |
GO:0060986 | endocrine hormone secretion | 7.101362e-3 |
GO:0042074 | cell migration involved in gastrulation | 7.258458e-3 |
GO:0016070 | RNA metabolic process | 7.329214e-3 |
GO:0050658 | RNA transport | 7.432242e-3 |
GO:0032225 | regulation of synaptic transmission, dopaminergic | 7.437410e-3 |
GO:0016554 | cytidine to uridine editing | 7.462133e-3 |
GO:0051043 | regulation of membrane protein ectodomain proteolysis | 7.566561e-3 |
GO:0048641 | regulation of skeletal muscle tissue development | 7.582047e-3 |
GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure | 7.618955e-3 |
GO:0043516 | regulation of DNA damage response, signal transduction by p53 class mediator | 7.685914e-3 |
GO:0060219 | camera-type eye photoreceptor cell differentiation | 8.179230e-3 |
GO:0045820 | negative regulation of glycolysis | 8.264459e-3 |
GO:0000381 | regulation of alternative nuclear mRNA splicing, via spliceosome | 8.301243e-3 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 8.319049e-3 |
GO:0043393 | regulation of protein binding | 8.376992e-3 |
GO:0034394 | protein localization at cell surface | 8.556134e-3 |
GO:0015931 | nucleobase-containing compound transport | 8.646648e-3 |
GO:0030031 | cell projection assembly | 8.801070e-3 |
GO:0051353 | positive regulation of oxidoreductase activity | 9.081145e-3 |
GO:0051131 | chaperone-mediated protein complex assembly | 9.103716e-3 |
GO:0045040 | protein import into mitochondrial outer membrane | 9.103716e-3 |
GO:0009048 | dosage compensation, by inactivation of X chromosome | 9.103716e-3 |
GO:0042176 | regulation of protein catabolic process | 9.140033e-3 |
GO:0007007 | inner mitochondrial membrane organization | 9.370866e-3 |
GO:0010628 | positive regulation of gene expression | 9.516508e-3 |
GO:0048484 | enteric nervous system development | 9.578773e-3 |
GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis | 9.789355e-3 |
GO:0006403 | RNA localization | 1.012543e-2 |
GO:0043281 | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 1.036541e-2 |
GO:0014894 | response to denervation involved in regulation of muscle adaptation | 1.043064e-2 |
GO:0060011 | Sertoli cell proliferation | 1.043064e-2 |
GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis | 1.043722e-2 |
GO:0045603 | positive regulation of endothelial cell differentiation | 1.043722e-2 |
GO:0046209 | nitric oxide metabolic process | 1.065857e-2 |
GO:0031123 | RNA 3'-end processing | 1.075931e-2 |
GO:0034762 | regulation of transmembrane transport | 1.078623e-2 |
GO:0016553 | base conversion or substitution editing | 1.135983e-2 |
GO:0032411 | positive regulation of transporter activity | 1.138974e-2 |
GO:2000116 | regulation of cysteine-type endopeptidase activity | 1.162677e-2 |
GO:0006927 | transformed cell apoptosis | 1.183759e-2 |
GO:0002070 | epithelial cell maturation | 1.252722e-2 |
GO:0006091 | generation of precursor metabolites and energy | 1.259332e-2 |
GO:0045010 | actin nucleation | 1.281912e-2 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.299660e-2 |
GO:0071841 | cellular component organization or biogenesis at cellular level | 1.309468e-2 |
GO:0045732 | positive regulation of protein catabolic process | 1.373301e-2 |
GO:0018191 | peptidyl-serine octanoylation | 1.388511e-2 |
GO:0031328 | positive regulation of cellular biosynthetic process | 1.416939e-2 |
GO:0003157 | endocardium development | 1.430637e-2 |
GO:0019941 | modification-dependent protein catabolic process | 1.441435e-2 |
GO:0043632 | modification-dependent macromolecule catabolic process | 1.471182e-2 |
GO:0046883 | regulation of hormone secretion | 1.481854e-2 |
GO:0007006 | mitochondrial membrane organization | 1.483906e-2 |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 1.483961e-2 |
GO:0016584 | nucleosome positioning | 1.488437e-2 |
GO:0048870 | cell motility | 1.513942e-2 |
GO:0043401 | steroid hormone mediated signaling pathway | 1.530187e-2 |
GO:0010832 | negative regulation of myotube differentiation | 1.596704e-2 |
GO:0010216 | maintenance of DNA methylation | 1.596704e-2 |
GO:0070301 | cellular response to hydrogen peroxide | 1.609043e-2 |
GO:0072283 | metanephric renal vesicle morphogenesis | 1.622140e-2 |
GO:0071456 | cellular response to hypoxia | 1.645125e-2 |
GO:0043271 | negative regulation of ion transport | 1.645125e-2 |
GO:0030858 | positive regulation of epithelial cell differentiation | 1.646941e-2 |
GO:0003347 | epicardial cell to mesenchymal cell transition | 1.652067e-2 |
GO:0071356 | cellular response to tumor necrosis factor | 1.660334e-2 |
GO:0051258 | protein polymerization | 1.671615e-2 |
GO:0034614 | cellular response to reactive oxygen species | 1.673415e-2 |
GO:0032770 | positive regulation of monooxygenase activity | 1.679365e-2 |
GO:0048821 | erythrocyte development | 1.686409e-2 |
GO:0030433 | ER-associated protein catabolic process | 1.706363e-2 |
GO:0071824 | protein-DNA complex subunit organization | 1.706426e-2 |
GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 1.708397e-2 |
GO:0048617 | embryonic foregut morphogenesis | 1.708397e-2 |
GO:0060850 | regulation of transcription involved in cell fate commitment | 1.737709e-2 |
GO:0070933 | histone H4 deacetylation | 1.765218e-2 |
GO:0010838 | positive regulation of keratinocyte proliferation | 1.765218e-2 |
GO:0033235 | positive regulation of protein sumoylation | 1.765218e-2 |
GO:0010466 | negative regulation of peptidase activity | 1.789718e-2 |
GO:0009891 | positive regulation of biosynthetic process | 1.795948e-2 |
GO:0001759 | organ induction | 1.797174e-2 |
GO:0044060 | regulation of endocrine process | 1.797174e-2 |
GO:0007435 | salivary gland morphogenesis | 1.801434e-2 |
GO:0048024 | regulation of nuclear mRNA splicing, via spliceosome | 1.808345e-2 |
GO:0014821 | phasic smooth muscle contraction | 1.827327e-2 |
GO:0090304 | nucleic acid metabolic process | 1.832154e-2 |
GO:0008285 | negative regulation of cell proliferation | 1.856219e-2 |
GO:0014874 | response to stimulus involved in regulation of muscle adaptation | 1.881561e-2 |
GO:0006548 | histidine catabolic process | 1.881561e-2 |
GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway | 1.883140e-2 |
GO:0072077 | renal vesicle morphogenesis | 1.919471e-2 |
GO:0042220 | response to cocaine | 1.935625e-2 |
GO:0032463 | negative regulation of protein homooligomerization | 1.940915e-2 |
GO:0000819 | sister chromatid segregation | 1.979250e-2 |
GO:0051726 | regulation of cell cycle | 1.998125e-2 |
GO:0009108 | coenzyme biosynthetic process | 2.009709e-2 |
GO:0090287 | regulation of cellular response to growth factor stimulus | 2.053781e-2 |
GO:0006547 | histidine metabolic process | 2.061955e-2 |
GO:0031330 | negative regulation of cellular catabolic process | 2.067804e-2 |
GO:0009438 | methylglyoxal metabolic process | 2.075537e-2 |
GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development | 2.078666e-2 |
GO:0071345 | cellular response to cytokine stimulus | 2.092729e-2 |
GO:0051155 | positive regulation of striated muscle cell differentiation | 2.160857e-2 |
GO:0034504 | protein localization to nucleus | 2.188538e-2 |
GO:0045601 | regulation of endothelial cell differentiation | 2.211087e-2 |
GO:0071453 | cellular response to oxygen levels | 2.234222e-2 |
GO:0032844 | regulation of homeostatic process | 2.247646e-2 |
GO:0006816 | calcium ion transport | 2.290445e-2 |
GO:0008593 | regulation of Notch signaling pathway | 2.309183e-2 |
GO:0031000 | response to caffeine | 2.325770e-2 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 2.339729e-2 |
GO:0030856 | regulation of epithelial cell differentiation | 2.339996e-2 |
GO:0008033 | tRNA processing | 2.343321e-2 |
GO:0006826 | iron ion transport | 2.374575e-2 |
GO:0001706 | endoderm formation | 2.399209e-2 |
GO:0010826 | negative regulation of centrosome duplication | 2.417258e-2 |
GO:0072091 | regulation of stem cell proliferation | 2.418160e-2 |
GO:0031060 | regulation of histone methylation | 2.453656e-2 |
GO:0010604 | positive regulation of macromolecule metabolic process | 2.487030e-2 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 2.530074e-2 |
GO:0030574 | collagen catabolic process | 2.598454e-2 |
GO:0042659 | regulation of cell fate specification | 2.598454e-2 |
GO:0001941 | postsynaptic membrane organization | 2.598454e-2 |
GO:0032237 | activation of store-operated calcium channel activity | 2.643925e-2 |
GO:0001656 | metanephros development | 2.645154e-2 |
GO:0032781 | positive regulation of ATPase activity | 2.672537e-2 |
GO:0016572 | histone phosphorylation | 2.672537e-2 |
GO:0060235 | lens induction in camera-type eye | 2.709999e-2 |
GO:0007440 | foregut morphogenesis | 2.709999e-2 |
GO:0045214 | sarcomere organization | 2.712210e-2 |
GO:0045078 | positive regulation of interferon-gamma biosynthetic process | 2.712236e-2 |
GO:0043010 | camera-type eye development | 2.747650e-2 |
GO:0046716 | muscle cell homeostasis | 2.785765e-2 |
GO:0050796 | regulation of insulin secretion | 2.828357e-2 |
GO:0033233 | regulation of protein sumoylation | 2.850977e-2 |
GO:0006349 | regulation of gene expression by genetic imprinting | 2.862650e-2 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 2.884041e-2 |
GO:0043491 | protein kinase B signaling cascade | 2.901513e-2 |
GO:0031325 | positive regulation of cellular metabolic process | 2.925351e-2 |
GO:0072087 | renal vesicle development | 2.940654e-2 |
GO:0060231 | mesenchymal to epithelial transition | 2.940654e-2 |
GO:2000465 | regulation of glycogen (starch) synthase activity | 2.980075e-2 |
GO:0030838 | positive regulation of actin filament polymerization | 2.980549e-2 |
GO:0006139 | nucleobase-containing compound metabolic process | 2.984169e-2 |
GO:0043620 | regulation of DNA-dependent transcription in response to stress | 3.019774e-2 |
GO:0010171 | body morphogenesis | 3.019870e-2 |
GO:0060562 | epithelial tube morphogenesis | 3.030616e-2 |
GO:0051928 | positive regulation of calcium ion transport | 3.034783e-2 |
GO:0034405 | response to fluid shear stress | 3.037165e-2 |
GO:0043270 | positive regulation of ion transport | 3.041163e-2 |
GO:0044257 | cellular protein catabolic process | 3.041493e-2 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 3.059753e-2 |
GO:0065003 | macromolecular complex assembly | 3.112375e-2 |
GO:0060037 | pharyngeal system development | 3.140545e-2 |
GO:0014074 | response to purine-containing compound | 3.210810e-2 |
GO:0048486 | parasympathetic nervous system development | 3.222448e-2 |
GO:0009314 | response to radiation | 3.243510e-2 |
GO:0006906 | vesicle fusion | 3.263816e-2 |
GO:0032963 | collagen metabolic process | 3.265593e-2 |
GO:0045494 | photoreceptor cell maintenance | 3.347384e-2 |
GO:0052547 | regulation of peptidase activity | 3.355388e-2 |
GO:0006809 | nitric oxide biosynthetic process | 3.358219e-2 |
GO:0055072 | iron ion homeostasis | 3.384991e-2 |
GO:0021903 | rostrocaudal neural tube patterning | 3.389582e-2 |
GO:0048561 | establishment of organ orientation | 3.435299e-2 |
GO:0007611 | learning or memory | 3.464006e-2 |
GO:0035239 | tube morphogenesis | 3.469727e-2 |
GO:0009755 | hormone-mediated signaling pathway | 3.469934e-2 |
GO:0051234 | establishment of localization | 3.475236e-2 |
GO:0042026 | protein refolding | 3.509146e-2 |
GO:0006917 | induction of apoptosis | 3.557024e-2 |
GO:0072088 | nephron epithelium morphogenesis | 3.575241e-2 |
GO:0001578 | microtubule bundle formation | 3.575241e-2 |
GO:0090073 | positive regulation of protein homodimerization activity | 3.585582e-2 |
GO:0042267 | natural killer cell mediated cytotoxicity | 3.585582e-2 |
GO:0055114 | oxidation-reduction process | 3.638355e-2 |
GO:0051225 | spindle assembly | 3.648563e-2 |
GO:0043584 | nose development | 3.648563e-2 |
GO:0061037 | negative regulation of cartilage development | 3.662660e-2 |
GO:0071478 | cellular response to radiation | 3.682497e-2 |
GO:0012502 | induction of programmed cell death | 3.685305e-2 |
GO:0045930 | negative regulation of mitotic cell cycle | 3.701813e-2 |
GO:0048255 | mRNA stabilization | 3.737087e-2 |
GO:0007549 | dosage compensation | 3.740373e-2 |
GO:0001824 | blastocyst development | 3.796733e-2 |
GO:0009790 | embryo development | 3.802486e-2 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 3.811048e-2 |
GO:0045072 | regulation of interferon-gamma biosynthetic process | 3.818716e-2 |
GO:0030030 | cell projection organization | 3.826468e-2 |
GO:0031497 | chromatin assembly | 3.840683e-2 |
GO:0034599 | cellular response to oxidative stress | 3.888856e-2 |
GO:0023019 | signal transduction involved in regulation of gene expression | 3.917413e-2 |
GO:0010453 | regulation of cell fate commitment | 3.917413e-2 |
GO:0010467 | gene expression | 3.935488e-2 |
GO:0006399 | tRNA metabolic process | 4.017009e-2 |
GO:0045786 | negative regulation of cell cycle | 4.047349e-2 |
GO:0019221 | cytokine-mediated signaling pathway | 4.065501e-2 |
GO:0042512 | negative regulation of tyrosine phosphorylation of Stat1 protein | 4.108100e-2 |
GO:0002071 | glandular epithelial cell maturation | 4.108100e-2 |
GO:0051341 | regulation of oxidoreductase activity | 4.164924e-2 |
GO:0035162 | embryonic hemopoiesis | 4.268234e-2 |
GO:0048742 | regulation of skeletal muscle fiber development | 4.274407e-2 |
GO:0000902 | cell morphogenesis | 4.297892e-2 |
GO:0042127 | regulation of cell proliferation | 4.298097e-2 |
GO:0043467 | regulation of generation of precursor metabolites and energy | 4.321777e-2 |
GO:0030204 | chondroitin sulfate metabolic process | 4.339007e-2 |
GO:0070683 | mitotic cell cycle G2/M transition decatenation checkpoint | 4.442745e-2 |
GO:0060133 | somatotropin secreting cell development | 4.442745e-2 |
GO:0006421 | asparaginyl-tRNA aminoacylation | 4.442745e-2 |
GO:0006928 | cellular component movement | 4.483666e-2 |
GO:0090276 | regulation of peptide hormone secretion | 4.497786e-2 |
GO:0001947 | heart looping | 4.523465e-2 |
GO:0051154 | negative regulation of striated muscle cell differentiation | 4.720605e-2 |
GO:0006733 | oxidoreduction coenzyme metabolic process | 4.727945e-2 |
GO:0001654 | eye development | 4.737663e-2 |
GO:0050684 | regulation of mRNA processing | 4.769327e-2 |
GO:0016191 | synaptic vesicle uncoating | 4.776225e-2 |
GO:0006110 | regulation of glycolysis | 4.782292e-2 |
GO:0044057 | regulation of system process | 4.819186e-2 |
GO:0072215 | regulation of metanephros development | 4.832870e-2 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | 4.837997e-2 |
GO:0009893 | positive regulation of metabolic process | 4.889687e-2 |
GO:0061303 | cornea development in camera-type eye | 4.892173e-2 |
GO:0072028 | nephron morphogenesis | 4.918228e-2 |
GO:0030163 | protein catabolic process | 5.007006e-2 |
GO:0034097 | response to cytokine stimulus | 5.054878e-2 |
GO:0045668 | negative regulation of osteoblast differentiation | 5.107927e-2 |
GO:0071206 | establishment of protein localization to juxtaparanode region of axon | 5.108544e-2 |
GO:0060168 | positive regulation of adenosine receptor signaling pathway | 5.108544e-2 |
GO:0019452 | L-cysteine catabolic process to taurine | 5.108544e-2 |
GO:0032413 | negative regulation of ion transmembrane transporter activity | 5.153702e-2 |
GO:0048754 | branching morphogenesis of a tube | 5.223900e-2 |
GO:0060042 | retina morphogenesis in camera-type eye | 5.262538e-2 |
GO:0002791 | regulation of peptide secretion | 5.311018e-2 |
GO:0072210 | metanephric nephron development | 5.340792e-2 |
GO:0043623 | cellular protein complex assembly | 5.381364e-2 |
GO:0071156 | regulation of cell cycle arrest | 5.386984e-2 |
GO:0048305 | immunoglobulin secretion | 5.420127e-2 |
GO:0032269 | negative regulation of cellular protein metabolic process | 5.425906e-2 |
GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development | 5.439706e-2 |
GO:0034699 | response to luteinizing hormone stimulus | 5.439706e-2 |
GO:0010157 | response to chlorate | 5.439706e-2 |
GO:0050890 | cognition | 5.494129e-2 |
GO:0090090 | negative regulation of canonical Wnt receptor signaling pathway | 5.585850e-2 |
GO:0051346 | negative regulation of hydrolase activity | 5.678934e-2 |
GO:0030522 | intracellular receptor mediated signaling pathway | 5.696385e-2 |
GO:0034612 | response to tumor necrosis factor | 5.731587e-2 |
GO:0070349 | positive regulation of brown fat cell proliferation | 5.769715e-2 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 5.769715e-2 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 5.769715e-2 |
GO:0043624 | cellular protein complex disassembly | 5.782749e-2 |
GO:0001708 | cell fate specification | 5.782804e-2 |
GO:0060442 | branching involved in prostate gland morphogenesis | 5.787641e-2 |
GO:0030866 | cortical actin cytoskeleton organization | 5.787641e-2 |
GO:0035272 | exocrine system development | 5.839833e-2 |
GO:0021532 | neural tube patterning | 5.864791e-2 |
GO:0043488 | regulation of mRNA stability | 5.906196e-2 |
GO:0001658 | branching involved in ureteric bud morphogenesis | 5.932363e-2 |
GO:0071845 | cellular component disassembly at cellular level | 5.966212e-2 |
GO:0006839 | mitochondrial transport | 5.966212e-2 |
GO:0033205 | cell cycle cytokinesis | 5.967142e-2 |
GO:0044260 | cellular macromolecule metabolic process | 5.995827e-2 |
GO:0016043 | cellular component organization | 6.109097e-2 |
GO:0060044 | negative regulation of cardiac muscle cell proliferation | 6.153541e-2 |
GO:0022411 | cellular component disassembly | 6.171620e-2 |
GO:0006405 | RNA export from nucleus | 6.181195e-2 |
GO:0018208 | peptidyl-proline modification | 6.200397e-2 |
GO:0034641 | cellular nitrogen compound metabolic process | 6.215891e-2 |
GO:0051153 | regulation of striated muscle cell differentiation | 6.225859e-2 |
GO:0001667 | ameboidal cell migration | 6.225859e-2 |
GO:0019432 | triglyceride biosynthetic process | 6.247480e-2 |
GO:0045765 | regulation of angiogenesis | 6.279871e-2 |
GO:0048013 | ephrin receptor signaling pathway | 6.285853e-2 |
GO:0043241 | protein complex disassembly | 6.341907e-2 |
GO:0007041 | lysosomal transport | 6.411543e-2 |
GO:0043487 | regulation of RNA stability | 6.415197e-2 |
GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 6.416271e-2 |